Disc Medicine, Inc. SEC filings IRON
Disc Medicine, Inc. has 778 filings in SEC EDGAR's recent list, going back to Jul 2, 2020. Its latest annual report, Form ARS, was filed on Apr 28, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Nov 19, 2024 | — |
| EFFECT | Filing | Dec 6, 2023 | — |
| EFFECT | Filing | Nov 29, 2023 | — |
| CORRESP | Letter to the SEC | Nov 27, 2023 | — |
| UPLOAD | Letter from the SEC | Nov 27, 2023 | — |
| EFFECT | Filing | Jan 24, 2023 | — |
| EFFECT | Filing | Jan 24, 2023 | — |
| CORRESP | Letter to the SEC | Jan 20, 2023 | — |
| CORRESP | Letter to the SEC | Jan 20, 2023 | — |
| UPLOAD | Letter from the SEC | Jan 19, 2023 | — |
| UPLOAD | Letter from the SEC | Jan 19, 2023 | — |
| 425 | Filing | Dec 27, 2022 | — |
| 425 | Filing | Dec 13, 2022 | — |
| 425 | Filing | Dec 8, 2022 | — |
| SEC STAFF LETTER | Filing | Dec 2, 2022 | — |
| EFFECT | Filing | Dec 2, 2022 | — |
| CORRESP | Letter to the SEC | Dec 1, 2022 | — |
| CORRESP | Letter to the SEC | Dec 1, 2022 | — |
| UPLOAD | Letter from the SEC | Nov 29, 2022 | — |
| CORRESP | Letter to the SEC | Nov 23, 2022 | — |
| UPLOAD | Letter from the SEC | Nov 17, 2022 | — |
| CORRESP | Letter to the SEC | Nov 2, 2022 | — |
| 425 | Filing | Oct 31, 2022 | — |
| SEC STAFF LETTER | Filing | Oct 28, 2022 | — |
| UPLOAD | Letter from the SEC | Oct 27, 2022 | — |
| CORRESP | Letter to the SEC | Oct 7, 2022 | — |
| UPLOAD | Letter from the SEC | Oct 3, 2022 | — |
| 425 | Filing | Aug 10, 2022 | — |
| 425 | Filing | Aug 10, 2022 | — |
| EFFECT | Filing | Mar 14, 2022 | — |
| EFFECT | Filing | Apr 28, 2021 | — |
| CORRESP | Letter to the SEC | Apr 26, 2021 | — |
| UPLOAD | Letter from the SEC | Feb 24, 2021 | — |
| CERT | Filing | Feb 8, 2021 | — |
| 8-A12B/A | Amendment no. 1 to form 8a-12b | Feb 5, 2021 | — |
| 25-NSE | Delisting notice | Feb 5, 2021 | — |
| 425 | Current report | Jan 28, 2021 | — |
| EFFECT | Filing | Jan 19, 2021 | — |
| 425 | Current report | Jan 19, 2021 | — |
| CORRESP | Letter to the SEC | Jan 19, 2021 | — |
| CORRESP | Letter to the SEC | Jan 11, 2021 | — |
| UPLOAD | Letter from the SEC | Jan 8, 2021 | — |
| CORRESP | Letter to the SEC | Dec 28, 2020 | — |
| UPLOAD | Letter from the SEC | Dec 18, 2020 | — |
| CORRESP | Letter to the SEC | Dec 7, 2020 | — |
| UPLOAD | Letter from the SEC | Nov 27, 2020 | — |
| 425 | Amendment no.1 to form 8-k | Oct 20, 2020 | — |
| 425 | Current report | Oct 15, 2020 | — |
| CERT | Filing | Aug 12, 2020 | — |
| EFFECT | Filing | Aug 11, 2020 | — |
| 8-A12B | Form 8-a12b | Aug 10, 2020 | — |
| DRS | Filing | Jul 2, 2020 | — |
Showing 52 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- IRON (Nasdaq)
- Fiscal year ends
- December 31
- Headquarters
- Watertown, MA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1816736
- Former names
- Gemini Therapeutics, Inc. /DE (until Dec 28, 2022); FS Development Corp. (until Feb 8, 2021)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.